You are here

Molecular Imaging


St. Louis-based Mallinckrodt closed the $690 million sale of its nuclear imaging division to IBA Molecular, a national supplier of radiopharmaceutical products.

For years now, research has emerged to show the effects of playing football—including repetitive concussive and sub-concussive hits—may lead to major brain damage. Now, a new study further explores the topic and affirms that players in the National Football League (NFL) could be at a higher risk for brain injuries.

Putting assumptions to rest in neuroscience, a group of researchers used an MRI approach and found that the connectivity patterns in your brain are unique to you.

Ionizing radiation from medical scans may be implicated in Alzheimer’s disease, according to a Danish study published in Oncotarget.

Katrina Pitas, vice president of business development for SHINE Medial Technologies, is in St. Louis this week to speak at the 2016 Mo-99 Topical Meeting. While preparing for her presentation, she spoke with Health Imaging about what SHINE has been up to this year and what she will be discussing at the meeting. 


Recent Headlines

MRI shows structural difference in cerebral cortices of patients with depression

Researchers from the Saban Research Institute of Children’s Hospital Los Angeles found structural differences in the cerebral cortex of patients with depression when examining brain MRI.

Can blueberry concentrate improve brain function in older patients?

A new study published in Applied Physiology, Nutrition, and Metabolism found that consuming blueberry concentrate over a 12-week period might help improve brain function in healthy older adults. 

NeuroVision to participate in Alzheimer’s A4 clinical trial

NeuroVision Imaging will take part in a new substudy with investigators at the University of California, San Diego (UCSD) School of Medicine and the University of Southern California as they take part in a landmark anti-amyloid treatment in asymptomatic Alzheimer’s (A4) clinical trial.

Study suggests ADHD is a disorder of the brain

A group of researchers who used neuroimaging to study the brain regions in children and adults with attention deficit hyperactivity disorder (ADHD) have found the condition should be considered a brain disorder.

Gamma Medica, Hospital Services Limited to expand into European breast imaging market

Gamma Medica, a molecular breast imaging (MBI) technology company, reached an agreement with Hospital Services Limited (HSL), a medical device company that distributes, installs and services radiology capital equipment and medical devices.

MRI detects signs of autism in high-risk infants

Researchers, who used MRI on infants who have older siblings with autism, were able to correctly predict about 80 percent of those infants who would later develop autism.

Mallinckrodt sells nuclear imaging business to IBA Molecular for $690 million

St. Louis-based Mallinckrodt closed the $690 million sale of its nuclear imaging division to IBA Molecular, a national supplier of radiopharmaceutical products.

Researchers pinpoint genetic risk factors for breast cancer

Clinicians may be able to more accurately predict a woman’s risk of breast cancer, as researchers from the University of Adelaide and the Hospital Research Foundation have identified a gene that contributes to tumor development in women with dense breasts.

Engineering company to test thrombectomy device in clinical trial

Amnis Therapeutics, a biomedical engineering company in Israel, has received approval from the Karolinska Institute, a medical university in Stockholm, Sweden, to use its neuro-thrombectomy device on patients for the first time in a clinical trial.

Parental obesity linked to slow development in children

A new study from the National Institutes of Health (NIH) found a link between slow development in young children and obesity rates of parents.